Piperacetazine

Piperacetazine
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
	IUPAC name 1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone;
CAS Number	3819-00-9 ;
PubChem CID	19675;
ChemSpider	18533;
UNII	KL6248WNW4;
ChEBI	CHEBI:92293;
ChEMBL	ChEMBL1584 ;
CompTox Dashboard (EPA)	DTXSID7023481 ;
ECHA InfoCard	100.021.194
Chemical and physical data
Formula	C24H30N2O2S
Molar mass	410.58 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(=O)c1ccc2Sc3ccccc3N(CCCN4CCC(CCO)CC4)c2c1;
	InChI InChI=InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3; Key:BTFMCMVEUCGQDX-UHFFFAOYSA-N;

Piperacetazine (Quide) is an antipsychotic prodrug, most notably used for schizophrenia.^[1] It is a phenothiazine derivative.

References

^ Rada RT, Donlon PT (February 1974). "Piperacetazine in ambulatory chronic schizophrenic patients". Current Therapeutic Research, Clinical and Experimental. 16 (2): 124–9. PMID 4156665.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.